Brookline Capital Markets lifted EPS estimates for Unicycive Therapeutics, Inc. on July 2, 2026.
3 reports, 1 independent
Updated Aug 1
Gone quiet
- Reports
- 3
- Developments
- 1
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Brookline Capital Markets lifted EPS estimates for Unicycive Therapeutics, Inc. on July 2, 2026.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Unicycive Therapeutics, Inc.
Unicycive Theraputics (Nasdaq: UNCY) is a clinical-stage biotechnology company focused on developing kidney medications
Nothing else this week.
-
Brookline
town in Massachusetts, United States